Development Level

Tchem 3 | 1,890
Tbio 2 | 10,625
Tclin 1 | 602

IMPC Term

decreased circulating creatini... 1 | 31
increased erythrocyte cell num... 1 | 26
preweaning lethality, complete... 1 | 633

Disease

Cancer 5 | 2,346
Mammary Neoplasms 4 | 410
atypical teratoid / rhabdoid tumor 4 | 4,369
osteosarcoma 4 | 7,933
Carcinoma 3 | 2,147
Lung Neoplasms 3 | 171
Prostatic Neoplasms 3 | 471
glioblastoma 3 | 5,572
lung cancer 3 | 4,466
psoriasis 3 | 6,685
Adenoma 2 | 165
Breast cancer 2 | 3,094
Diarrhea 2 | 155
Exanthem 2 | 39
Fibrosis 2 | 40
Heart disease 2 | 279
Mammary Neoplasms, Experimental 2 | 150
Toxic encephalopathy 2 | 131
Vascular disease 2 | 281
ependymoma 2 | 2,514
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
malignant mesothelioma 2 | 3,162
medulloblastoma, large-cell 2 | 6,234
non-small cell lung carcinoma 2 | 413
ovarian cancer 2 | 8,484
ovarian neoplasm 2 | 97
pediatric high grade glioma 2 | 2,712
ulcerative colitis 2 | 2,087
Adenocarcinoma 1 | 115
Adenocarcinoma of lung (disorder) 1 | 48
Adenomatous Polyposis Coli 1 | 10
Alopecia 1 | 55
Animal Mammary Neoplasms 1 | 136
Barrett's esophagus 1 | 183
Brain disease 1 | 83
Breast adenocarcinoma 1 | 8
Breast disease 1 | 8
Breast fibroadenoma 1 | 8
Carcinogenesis 1 | 6
Cardiomegaly 1 | 66
Cardiomyopathies 1 | 90
Cholangiocarcinoma 1 | 32
Chronic Myelocytic Leukemia Accelerated Phase 1 | 59
Colon Carcinoma 1 | 25
Colonic Neoplasms 1 | 126
Colorectal Neoplasms 1 | 217
Comedo carcinoma 1 | 2
Cowden disease 1 | 16
Diabetic Retinopathy 1 | 53
Disease Progression 1 | 125
Epilepsy 1 | 346
Esophageal Neoplasms 1 | 67
Ewing sarcoma 1 | 26
Fatty liver disease 1 | 84
GLIOMA SUSCEPTIBILITY 1 1 | 3
Gastrointestinal Neoplasms 1 | 4
Glioma 1 | 65
HER2 Positive Carcinoma of Breast 1 | 2
HER2-positive carcinoma of breast 1 | 10
Heart failure 1 | 80
Hyperglycemia 1 | 120
Hyperinsulinism 1 | 63
Inflammation 1 | 109
Kidney cancer 1 | 118
Liver disease 1 | 219
Lobular neoplasia 1 | 15
Lymphatic Metastasis 1 | 14
Malignant neoplasm of breast 1 | 63
Meningioma 1 | 26
Muscular atrophy 1 | 67
Myopathy 1 | 128
Neoplasm Metastasis 1 | 138
Neoplasm Recurrence, Local 1 | 23
Neoplasms, Experimental 1 | 33
Neuroblastoma 1 | 78
Neurofibromatosis 1 | 37
Neuropathy 1 | 210
Neutropenia 1 | 78
Non-small cell lung cancer, positive for epidermal growth factor receptor expression 1 | 4
Osteoporosis 1 | 257
Pain 1 | 70
Papilloma 1 | 27
Parkinson's disease 1 | 364
Paronychia 1 | 7
Pleomorphic adenoma 1 | 18
Precancerous Conditions 1 | 69
Psychoses, Substance-Induced 1 | 17
Renal Cell Carcinoma 1 | 199
Retinal Degeneration 1 | 49
Secondary malignant neoplasm of female breast 1 | 3
Secondary malignant neoplasm of stomach 1 | 2
Skin Neoplasms 1 | 49
Skin cancer 1 | 37
Skin disease 1 | 65
Squamous cell carcinoma 1 | 94
Stomach Neoplasms 1 | 282
Stomatitis 1 | 19
Thrombocytopenia 1 | 105
Trichorhinophalangeal syndrome type II 1 | 14
gallbladder neoplasm 1 | 9

Tissue

Blood and immune system 6 | 17,995
Cardiovascular System 6 | 17,958
Digestive Tract 6 | 18,473
Endocrine System 6 | 18,512
Female tissues 6 | 18,647
Liver and Pancreas 6 | 18,136
Male tissues 6 | 17,969
Nervous System 6 | 18,561
Respiratory system 6 | 17,484
Skin and soft tissues 6 | 18,115
Urinary Tract 6 | 18,444

Target Family

Kinase 4 | 634
Transcription Factor 2 | 1,400

Grant Application

7R01CA116623-05 6 | 6
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Zinc fingers and homeoboxes protein 2 ZHX2 Tbio Transcription Factor -1.56015 38.3 435
Receptor tyrosine-protein kinase erbB-2 ERBB2 Tclin Kinase -4.22922 19000.3 3336
Dual specificity mitogen-activated protein kinase kinase 7 MAP2K7 Tchem Kinase -3.60765 3454.0 459
ETS translocation variant 4 ETV4 Tbio Transcription Factor -2.37868 232.8 182
RAC-alpha serine/threonine-protein kinase AKT1 Tchem Kinase -4.29533 18275.3 3137
Ephrin type-B receptor 2 EPHB2 Tchem Kinase -2.63936 472.2 420